Skip to main content
OpenTrials

Clinical trial condition

High Grade B-Cell Lymphoma, Not Otherwise Specified

Explore clinical trials studying High Grade B-Cell Lymphoma, Not Otherwise Specified. Study availability and eligibility vary by location and protocol.

14 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

High Grade B-Cell Lymphoma, Not Otherwise Specified trial results

Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

NCT06544265

Conditions
Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations
  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
View Trial Details
Recruiting

A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies

NCT05908409

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +31 more
Locations
  • Hospital Universitario Marques de Valdecilla Santander, Cantabria, Spain
  • Hospital Universitario de Salamanca Salamanca, Castille and León, Spain
  • Hospital Universitari Vall d'hebron Barcelona, Spain
  • Hospital Durán i Reynals - ICO L´Hospitalet Barcelona, Spain
View Trial Details
Completed

Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma

NCT03742258

Conditions
Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, +15 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Northwestern Lake Forest Hospital Lake Forest, Illinois, United States
View Trial Details
Active, Not Recruiting

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas

NCT03984448

Conditions
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Diffuse Large B-cell Lymphoma, Double-Expressor Lymphoma, +16 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 635 locations
View Trial Details
Active, Not Recruiting

Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

NCT04799275

Conditions
Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma, +30 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 176 locations
View Trial Details

Related conditions